$AMBA
AMBARELLA INC Stock $amba

$amba Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000156459020028586 Filed on June 08, 2020

Income Statement

Concept	2020 Q2	2020 Q1	2019 Q2
Revenue	$54.65M	$57.20M	$47.19M
YoY Change	15.8%	11.94%	-17.07%
Cost Of Revenue	$22.63M	$23.90M	$19.34M
YoY Change	17.02%	17.16%	-12.11%
Gross Profit	$32.02M	$33.30M	$27.85M
YoY Change	14.96%	8.47%	-20.19%
Gross Profit Margin	58.6%	58.22%	59.03%
Selling, General & Admin	$13.44M	$13.30M	$13.08M
YoY Change	2.74%	7.26%	-0.93%
% of Gross Profit	41.96%	39.94%	46.95%
Research & Development	$34.20M	$33.80M	$33.02M
YoY Change	3.58%	3.68%	4.15%
% of Gross Profit	106.81%	101.5%	118.54%
Depreciation & Amortization	$700.0K	$3.400M	$700.0K
YoY Change	0.0%	78.95%	16.67%
% of Gross Profit	2.19%	10.21%	2.51%
Operating Expenses	$47.64M	$47.10M	$46.09M
YoY Change	3.34%	4.67%	2.66%
Operating Profit	-$15.62M	-$13.80M	-$18.24M
YoY Change	-14.4%	-3.5%	82.41%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$1.278M	$1.700M	$2.196M
YoY Change	-41.8%	-50.0%	174.5%
Pretax Income	-$14.34M	-$12.10M	-$16.05M
YoY Change	-10.65%	10.0%	75.2%
Income Tax	$1.100M	$900.0K	$1.300M
% Of Pretax Income
Net Earnings	-$15.46M	-$13.00M	-$17.31M
YoY Change	-10.68%	188.89%	73.01%
Net Earnings / Revenue	-28.3%	-22.73%	-36.69%
Basic Earnings Per Share	-$0.45		-$0.53
Diluted Earnings Per Share	-$0.45	-$385.8K	-$0.53
COMMON SHARES
Basic Shares Outstanding	34.08M		32.49M
Diluted Shares Outstanding	34.08M		32.49M

Balance Sheet

Concept	2020 Q2	2020 Q1	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$411.3M	$404.7M	$366.2M
YoY Change	12.32%	12.77%	-11.57%
Cash & Equivalents	$236.6M	$231.4M	$204.4M
Short-Term Investments	$174.7M	$173.3M	$161.7M
Other Short-Term Assets	$4.800M	$5.000M	$5.000M
YoY Change	-4.0%	-19.35%	31.58%
Inventory	$21.96M	$22.97M	$17.60M
Prepaid Expenses
Receivables	$20.70M	$18.49M	$26.50M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$458.8M	$451.2M	$415.3M
YoY Change	10.47%	10.16%	-10.99%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.401M	$5.614M	$14.30M
YoY Change	-62.23%	0.0%	116.67%
Goodwill		$26.60M
YoY Change		0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$15.30M	$5.710M	$12.90M
YoY Change	18.6%	136.73%	115.0%
Total Long-Term Assets	$72.90M	$76.09M	$64.00M
YoY Change	13.91%	32.87%	21.67%
TOTAL ASSETS
Total Short-Term Assets	$458.8M	$451.2M	$415.3M
Total Long-Term Assets	$72.90M	$76.09M	$64.00M
Total Assets	$531.7M	$527.3M	$479.3M
YoY Change	10.93%	12.94%	-7.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$20.60M	$14.91M	$16.10M
YoY Change	27.95%	16.48%	-7.47%
Accrued Expenses	$29.40M	$37.20M	$24.90M
YoY Change	18.07%	50.61%	16.9%
Deferred Revenue		$701.0K	$565.0K
YoY Change		32.51%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$51.50M	$53.45M	$42.22M
YoY Change	21.99%	36.98%	6.34%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$17.26M	$17.78M	$13.30M
YoY Change	29.78%	113.12%	41.49%
Total Long-Term Liabilities	$17.26M	$17.78M	$13.30M
YoY Change	29.78%	113.12%	41.49%
TOTAL LIABILITIES
Total Short-Term Liabilities	$51.50M	$53.45M	$42.22M
Total Long-Term Liabilities	$17.26M	$17.78M	$13.30M
Total Liabilities	$76.20M	$79.20M	$56.80M
YoY Change	34.15%	67.22%	12.92%
SHAREHOLDERS EQUITY
Retained Earnings		$186.1M
YoY Change		-19.4%
Common Stock		$261.2M
YoY Change		38.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$455.6M	$448.1M	$422.4M
YoY Change
Total Liabilities & Shareholders Equity	$531.7M	$527.3M	$479.3M
YoY Change	10.93%	12.94%	-7.68%

Cashflow Statement

Concept	2020 Q2	2020 Q1	2019 Q2
OPERATING ACTIVITIES
Net Income	-$15.46M	-$13.00M	-$17.31M
YoY Change	-10.68%	188.89%	73.01%
Depreciation, Depletion And Amortization	$700.0K	$3.400M	$700.0K
YoY Change	0.0%	78.95%	16.67%
Cash From Operating Activities	$7.639M	$4.100M	$5.332M
YoY Change	43.27%	-70.71%	8231.25%
INVESTING ACTIVITIES
Capital Expenditures	$428.0K	-$400.0K	$513.0K
YoY Change	-16.57%	-20.0%	-23.55%
Acquisitions
YoY Change
Other Investing Activities	-$1.700M	-$24.60M	$3.600M
YoY Change	-147.22%	-11.83%	-65.38%
Cash From Investing Activities	-$2.164M	-$25.00M	$3.122M
YoY Change	-169.31%	-11.97%	-67.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$1.000M	$1.000M	$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-293.0K	-100.0K	1.943M
YoY Change	-115.08%	-97.37%	-109.84%
NET CHANGE
Cash From Operating Activities	7.639M	4.100M	5.332M
Cash From Investing Activities	-2.164M	-25.00M	3.122M
Cash From Financing Activities	-293.0K	-100.0K	1.943M
Net Change In Cash	5.182M	-21.00M	10.40M
YoY Change	-50.16%	15.38%	-204.18%
FREE CASH FLOW
Cash From Operating Activities	$7.639M	$4.100M	$5.332M
Capital Expenditures	$428.0K	-$400.0K	$513.0K
Free Cash Flow	$7.211M	$4.500M	$4.819M
YoY Change	49.64%	-68.97%	-893.9%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3M10D
CY2020Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y7M2D
CY2020Q2	us-gaap	Gross Profit GrossProfit	32020000
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-15463000
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-17311000
CY2020Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-363000
CY2019Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	254000
CY2020Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1000000
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	15214000
CY2020Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-363000
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-15463000
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	419489000
CY2019Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1520000
CY2019Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	3063000
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	15423000
CY2019Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	254000
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-17311000
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	422438000
CY2020Q2	us-gaap	Profit Loss ProfitLoss	-15463000
CY2019Q2	us-gaap	Profit Loss ProfitLoss	-17311000
CY2020Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2872000
CY2019Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2708000
CY2020Q2	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-10000
CY2019Q2	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	378000
CY2020Q2	us-gaap	Share Based Compensation ShareBasedCompensation	16036000
CY2019Q2	us-gaap	Share Based Compensation ShareBasedCompensation	16460000
CY2020Q2	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	457000
CY2019Q2	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	21000
CY2020Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	38000
CY2019Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-142000
CY2020Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2197000
CY2019Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	245000
CY2020Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1014000
CY2019Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-617000
CY2020Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-193000
CY2019Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1007000
CY2020Q2	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-351000
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	22625000
CY2019Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	19335000
CY2019Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13077000
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	47635000
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	46094000
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-15615000
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-18241000
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1278000
CY2019Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2196000
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6463000
CY2020Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2660000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	455583000
CY2019Q2	us-gaap	Gross Profit GrossProfit	27853000
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	34200000
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	33017000
CY2020Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13435000
CY2019Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	11000
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	194058000
CY2020Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	211800000
CY2020Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	211800000
CY2020Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	211081000
CY2019Q2	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-60000
CY2020Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5679000
CY2019Q2	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	35583000
CY2020Q2	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	13601000
CY2019Q2	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	10023000
CY2019Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3254000
CY2019Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-454000
CY2020Q2	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	33740000
CY2019Q2	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	29195000
CY2020Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	428000
CY2019Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	513000
CY2020Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2164000
CY2020Q2	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	101000
CY2019Q2	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	36000
CY2020Q2	amba	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-689000
CY2019Q2	amba	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-727000
CY2020Q2	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	598000
CY2019Q2	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	453000
CY2020Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7639000
CY2019Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5332000
CY2020Q2	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	49077000
CY2019Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3122000
CY2020Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1000000
CY2020Q2	amba	Proceeds From Issuance Of Shares Under Incentive Equity Plan And Employee Stock Purchase Plan ProceedsFromIssuanceOfSharesUnderIncentiveEquityPlanAndEmployeeStockPurchasePlan	1912000
CY2019Q2	amba	Proceeds From Issuance Of Shares Under Incentive Equity Plan And Employee Stock Purchase Plan ProceedsFromIssuanceOfSharesUnderIncentiveEquityPlanAndEmployeeStockPurchasePlan	2938000
CY2020Q2	amba	Payment For Intangible Asset PaymentForIntangibleAsset	1205000
CY2019Q2	amba	Payment For Intangible Asset PaymentForIntangibleAsset	995000
CY2020Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-293000
CY2019Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1943000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5182000
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10397000
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	231412000
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	194058000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	236594000
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	204455000
CY2019Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid	797000
CY2020Q2	amba	Capital Expenditures Incurred But Not Yet Paid And Financing Incurred For Tangible And Intangible Asset Purchased CapitalExpendituresIncurredButNotYetPaidAndFinancingIncurredForTangibleAndIntangibleAssetPurchased	67000
CY2019Q2	amba	Capital Expenditures Incurred But Not Yet Paid And Financing Incurred For Tangible And Intangible Asset Purchased CapitalExpendituresIncurredButNotYetPaidAndFinancingIncurredForTangibleAndIntangibleAssetPurchased	372000
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	236585000
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	231403000
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	204444000
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	194047000
CY2020Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	9000
CY2020Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	9000
CY2019Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	11000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	236594000
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	231412000
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	204455000
CY2020Q2	us-gaap	Inventory Write Down InventoryWriteDown	0
CY2019Q2	us-gaap	Inventory Write Down InventoryWriteDown	0
CY2020Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	211395000
CY2020Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1022000
CY2020Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	211800000
CY2020Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	210313000
CY2020Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	770000
CY2020Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2000
CY2020Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	211081000
CY2020Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	0
CY2020Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	211081000
CY2020Q2	amba	Available For Sale Securities Debt Maturities Within One Year AvailableForSaleSecuritiesDebtMaturitiesWithinOneYear	144722000
CY2020Q1	amba	Available For Sale Securities Debt Maturities Within One Year AvailableForSaleSecuritiesDebtMaturitiesWithinOneYear	146267000
CY2020Q2	amba	Available For Sale Securities Debt Maturities Within One To Three Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneToThreeYearsFairValue	67078000
CY2020Q1	amba	Available For Sale Securities Debt Maturities Within One To Three Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneToThreeYearsFairValue	64814000
CY2020Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	211081000
CY2020Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	12773000
CY2020Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	10133000
CY2020Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	9184000
CY2020Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	12838000
CY2020Q2	us-gaap	Inventory Net InventoryNet	21957000
CY2020Q1	us-gaap	Inventory Net InventoryNet	22971000
CY2020Q2	us-gaap	Depreciation Depreciation	700000
CY2019Q2	us-gaap	Depreciation Depreciation	700000
CY2020Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20394000
CY2019Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	19987000
CY2020Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	14993000
CY2019Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	14373000
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5401000
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5614000
CY2020Q2	amba	Liabilities Associated With Noncancelable Internal Use Software License At Net Present Value Current LiabilitiesAssociatedWithNoncancelableInternalUseSoftwareLicenseAtNetPresentValueCurrent	4400000
CY2020Q2	amba	Liabilities Associated With Noncancelable Internal Use Software License At Net Present Value Noncurrent LiabilitiesAssociatedWithNoncancelableInternalUseSoftwareLicenseAtNetPresentValueNoncurrent	7000000.0
CY2020Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	31391000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15000000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16391000
CY2020Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	31303000
CY2020Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	13477000
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	17826000
CY2020Q2	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2019Q2	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2020Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9949000
CY2020Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	16874000
CY2020Q2	amba	Accrued Rebates AccruedRebates	90000
CY2020Q1	amba	Accrued Rebates AccruedRebates	54000
CY2020Q2	amba	Accrued Development Cost Liabilities AccruedDevelopmentCostLiabilities	10454000
CY2020Q1	amba	Accrued Development Cost Liabilities AccruedDevelopmentCostLiabilities	10885000
CY2020Q2	amba	Liabilities Associated With Noncancelable Internal Use Software License At Net Present Value Current LiabilitiesAssociatedWithNoncancelableInternalUseSoftwareLicenseAtNetPresentValueCurrent	4386000
CY2020Q1	amba	Liabilities Associated With Noncancelable Internal Use Software License At Net Present Value Current LiabilitiesAssociatedWithNoncancelableInternalUseSoftwareLicenseAtNetPresentValueCurrent	4388000
CY2020Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2383000
CY2020Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2769000
CY2020Q2	amba	Accrued And Other Liabilities Current AccruedAndOtherLiabilitiesCurrent	27262000
CY2020Q1	amba	Accrued And Other Liabilities Current AccruedAndOtherLiabilitiesCurrent	34970000
CY2020Q1	amba	Payments For Bonus PaymentsForBonus	7700000
CY2020Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	700000
CY2019Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	700000
CY2020Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	689000
CY2020Q2	amba	Lease Liabilities Arising From Obtaining Right Of Use Assets For Operating Lease LeaseLiabilitiesArisingFromObtainingRightOfUseAssetsForOperatingLease	88000
CY2020Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y10M24D
CY2020Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	275000000.0
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	4011595
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	10424000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	937000
CY2020Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	9487000
CY2020Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0443
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1784000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2355000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1644000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1693000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1740000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1208000
CY2020Q2	amba	Unrecognized Tax Benefits Including Interest UnrecognizedTaxBenefitsIncludingInterest	8782000
CY2020Q1	amba	Unrecognized Tax Benefits Including Interest UnrecognizedTaxBenefitsIncludingInterest	8261000
CY2020Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1287000
CY2020Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1288000
CY2020Q2	amba	Liabilities Associated With Noncancelable Internal Use Software License At Net Present Value Noncurrent LiabilitiesAssociatedWithNoncancelableInternalUseSoftwareLicenseAtNetPresentValueNoncurrent	7046000
CY2020Q1	amba	Liabilities Associated With Noncancelable Internal Use Software License At Net Present Value Noncurrent LiabilitiesAssociatedWithNoncancelableInternalUseSoftwareLicenseAtNetPresentValueNoncurrent	8159000
CY2020Q2	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	146000
CY2020Q1	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	68000
CY2020Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	17261000
CY2020Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	17776000
CY2020Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2020Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2020Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00045
CY2020Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00045
CY2020Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2020Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	25719
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1000000.0
CY2016Q2	amba	Stock Repurchase Program Inception Month And Year StockRepurchaseProgramInceptionMonthAndYear	2016-06
CY2019Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16460000
CY2020Q2	amba	Accrued Share Based Compensation Expense AccruedShareBasedCompensationExpense	800000
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	7200
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	23.85
CY2020Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	75870
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3369000
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2929
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	350
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	175800000
CY2020Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	49000000.0
CY2020Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16036000
CY2020Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	40.60
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1052697
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	34.33
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	22404000
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	903782
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	31.92
CY2020Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	21555000
CY2020Q2	amba	Closing Market Price Of Ordinary Shares On Nasdaq On Last Day Of Reporting Period ClosingMarketPriceOfOrdinarySharesOnNASDAQOnLastDayOfReportingPeriod	52.58
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-15463000
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-17311000
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34080330
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32492044
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34080330
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32492044
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.53
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.53
CY2020Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2244323
CY2019Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1946685
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14337000
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16045000
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1126000
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1266000
CY2020Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.079
CY2019Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.079
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1100000
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1300000
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	43300000
CY2020Q2	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	32600000
CY2020Q1	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	35900000
CY2020Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	54645000
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47188000

Files In Submission

Name	View Source	Status
0001564590-20-028586-index-headers.html	Edgar Link	pending
0001564590-20-028586-index.html	Edgar Link	pending
0001564590-20-028586.txt	Edgar Link	pending
0001564590-20-028586-xbrl.zip	Edgar Link	pending
amba-10q_20200430.htm	Edgar Link	pending
amba-10q_20200430_htm.xml	Edgar Link	completed
amba-20200430.xsd	Edgar Link	pending
amba-20200430_cal.xml	Edgar Link	unprocessable
amba-20200430_def.xml	Edgar Link	unprocessable
amba-20200430_lab.xml	Edgar Link	unprocessable
amba-20200430_pre.xml	Edgar Link	unprocessable
amba-ex311_8.htm	Edgar Link	pending
amba-ex312_6.htm	Edgar Link	pending
amba-ex321_9.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMBA
AMBARELLA INC Stock $amba

2020 Q2 Form 10-Q Financial Statement

#000156459020028586 Filed on June 08, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMBA AMBARELLA INC Stock $amba

2020 Q2 Form 10-Q Financial Statement

#000156459020028586 Filed on June 08, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMBA
AMBARELLA INC Stock $amba